期刊： ENDOCRINOLOGY DIABETES & METABOLISM, 2022; 5 (4)
Objective To delineate the prevalence and associated risk factors of low BMD, osteoporosis/bone fragility and fracture in transfusion-dependent thalas......
期刊： ENDOCRINOLOGY DIABETES & METABOLISM, 2022; 5 (1)
Aims Type 2 diabetes mellitus (T2DM) is a strong risk factor for complications of coronavirus disease 2019 (COVID-19). The effect of T2DM medications ......
期刊： ENDOCRINOLOGY DIABETES & METABOLISM, 2022; 5 (1)
Introduction The purpose of this study was to evaluate the therapeutic effectiveness of Chinese patent medicines containing red yeast rice for the tre......
期刊： ENDOCRINOLOGY DIABETES & METABOLISM, 2021; 4 (3)
Introduction The present study evaluated the application of incorporating non-linear J/U-shaped relationships between mean HbA1c and cholesterol level......
期刊： ENDOCRINOLOGY DIABETES & METABOLISM, 2021; 4 (3)
Background Patients with type 2 diabetes (T2D) are predisposed to derangements in serum Magnesium (Mg), which may have implications for cardiometaboli......
期刊： ENDOCRINOLOGY DIABETES & METABOLISM, 2021; 4 (3)
Aim Heparin, a widely used antithrombotic drug has many other anticoagulant-independent physiological functions. Here, we elucidate a novel role of he......
期刊： ENDOCRINOLOGY DIABETES & METABOLISM, 2021; 4 (3)
Background Although there is preponderance of literature on disease burden of diabetes in developed countries, limited investigations have been conduc......
期刊： ENDOCRINOLOGY DIABETES & METABOLISM, 2021; 4 (3)
Objective Sulfonylureas and dipeptidyl peptidase-4 inhibitors have a multidirectional effect on pancreatic cells. We aimed to evaluate the effects of ......
